104 related articles for article (PubMed ID: 11121865)
1. Improvement of gene transfer to cervical cancer cell lines using non-viral agents.
Cho CW; Cho YS; Kang BT; Hwang JS; Park SN; Yoon DY
Cancer Lett; 2001 Jan; 162(1):75-85. PubMed ID: 11121865
[TBL] [Abstract][Full Text] [Related]
2. Improvement of receptor-mediated gene delivery to HepG2 cells using an amphiphilic gelling agent.
Cho CW; Cho YS; Lee HK; Yeom YI; Park SN; Yoon DY
Biotechnol Appl Biochem; 2000 Aug; 32(1):21-6. PubMed ID: 10918034
[TBL] [Abstract][Full Text] [Related]
3. Gene transfer using recombinant rabbit hemorrhagic disease virus capsids with genetically modified DNA encapsidation capacity by addition of packaging sequences from the L1 or L2 protein of human papillomavirus type 16.
El Mehdaoui S; Touzé A; Laurent S; Sizaret PY; Rasschaert D; Coursaget P
J Virol; 2000 Nov; 74(22):10332-40. PubMed ID: 11044077
[TBL] [Abstract][Full Text] [Related]
4. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus-like particles mediate functional delivery of plasmid DNA to antigen presenting cells in vivo.
Malboeuf CM; Simon DA; Lee YE; Lankes HA; Dewhurst S; Frelinger JG; Rose RC
Vaccine; 2007 Apr; 25(17):3270-6. PubMed ID: 17293010
[TBL] [Abstract][Full Text] [Related]
6. In vitro gene transfer using human papillomavirus-like particles.
Touze A; Coursaget P
Nucleic Acids Res; 1998 Mar; 26(5):1317-23. PubMed ID: 9469843
[TBL] [Abstract][Full Text] [Related]
7. Expression of human papillomavirus type 6 L1 and L2 isolated in China and self assembly of virus-like particles by the products.
Wang M; Wang LL; Chen LF; Han YH; Zou YH; Si JY; Song GX
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jan; 35(1):27-34. PubMed ID: 12518224
[TBL] [Abstract][Full Text] [Related]
8. Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV).
Huber B; Schellenbacher C; Shafti-Keramat S; Jindra C; Christensen N; Kirnbauer R
PLoS One; 2017; 12(1):e0169533. PubMed ID: 28056100
[TBL] [Abstract][Full Text] [Related]
9. Generation of HPV pseudovirions using transfection and their use in neutralization assays.
Buck CB; Pastrana DV; Lowy DR; Schiller JT
Methods Mol Med; 2005; 119():445-62. PubMed ID: 16350417
[TBL] [Abstract][Full Text] [Related]
10. Recombinant VLP-Z of JC Polyomavirus: A Novel Vector for Targeting Gene Delivery.
Deng YN; Zeng JY; Su H; Qu QM
Intervirology; 2015; 58(6):363-8. PubMed ID: 26909539
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B Virus-Like Particle: Targeted Delivery of Plasmid Expressing Short Hairpin RNA for Silencing the
Akwiditya MA; Yong CY; Yusof MT; Mariatulqabtiah AR; Ho KL; Tan WS
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652577
[TBL] [Abstract][Full Text] [Related]
12. Mutant canine oral papillomavirus L1 capsid proteins which form virus-like particles but lack native conformational epitopes.
Chen Y; Ghim SJ; Jenson AB; Schlegel R
J Gen Virol; 1998 Sep; 79 ( Pt 9)():2137-46. PubMed ID: 9747722
[TBL] [Abstract][Full Text] [Related]
13. Efficient gene transfer to dispersed human pancreatic islet cells in vitro using adenovirus-polylysine/DNA complexes or polycationic liposomes.
Saldeen J; Curiel DT; Eizirik DL; Andersson A; Strandell E; Buschard K; Welsh N
Diabetes; 1996 Sep; 45(9):1197-203. PubMed ID: 8772722
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe.
Sasagawa T; Pushko P; Steers G; Gschmeissner SE; Hajibagheri MA; Finch J; Crawford L; Tommasino M
Virology; 1995 Jan; 206(1):126-35. PubMed ID: 7831768
[TBL] [Abstract][Full Text] [Related]
15. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
Yang R; Wheeler CM; Chen X; Uematsu S; Takeda K; Akira S; Pastrana DV; Viscidi RP; Roden RB
J Virol; 2005 Jun; 79(11):6741-50. PubMed ID: 15890912
[TBL] [Abstract][Full Text] [Related]
16. Enhanced mucosal and systemic immunogenicity of human papillomavirus-like particles encapsidating interleukin-2 gene adjuvant.
Oh YK; Sohn T; Park JS; Kang MJ; Choi HG; Kim JA; Kim WK; Ko JJ; Kim CK
Virology; 2004 Oct; 328(2):266-73. PubMed ID: 15464846
[TBL] [Abstract][Full Text] [Related]
17. Co-vaccination with adeno-associated virus vectors encoding human papillomavirus 16 L1 proteins and adenovirus encoding murine GM-CSF can elicit strong and prolonged neutralizing antibody.
Liu DW; Chang JL; Tsao YP; Huang CW; Kuo SW; Chen SL
Int J Cancer; 2005 Jan; 113(1):93-100. PubMed ID: 15386434
[TBL] [Abstract][Full Text] [Related]
18. Gene transfer into hepatoma cell lines via the serpin enzyme complex receptor.
Ziady AG; Perales JC; Ferkol T; Gerken T; Beegen H; Perlmutter DH; Davis PB
Am J Physiol; 1997 Aug; 273(2 Pt 1):G545-52. PubMed ID: 9277436
[TBL] [Abstract][Full Text] [Related]
19. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
20. Lectin conjugate-directed gene transfer to airway epithelial cells.
Yin W; Cheng PW
Biochem Biophys Res Commun; 1994 Nov; 205(1):826-33. PubMed ID: 7999119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
